Bayer has entered into a collaboration with the biotech company Meiogenix, which is focused on next-generation breeding technologies. The collaboration is aimed at advancing agricultural research and development through the accelerated development of Meiogenix’s proprietary technologies related to plant breeding and genome editing applications. Through the collaboration, Bayer will have access to these proprietary technologies, potentially improving the precision and speed with which the company can develop enhanced crops.